Literature DB >> 12623117

Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods.

Christopher J Endres1, Badreddine Bencherif, John Hilton, Igal Madar, J James Frost.   

Abstract

[(11)C]Carfentanil (CFN) is a mu-opioid agonist used for in vivo positron emission tomography (PET) studies of mu-opioid receptors. Previously, a tissue-ratio method was validated for the quantification of CFN binding. However, since that initial validation, several other blood independent (reference-tissue) methods have become available. To evaluate these methods, CFN PET studies with arterial blood sampling were acquired in six healthy male control subjects. Specific binding estimates obtained from reference-tissue methods were compared to those obtained with a more rigorous blood input modeling technique. It was determined that both a graphical method, and a simplified reference tissue model, were more accurate than the tissue-ratio method for quantification of CFN binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623117     DOI: 10.1016/s0969-8051(02)00411-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  24 in total

Review 1.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

2.  Improving PET receptor binding estimates from Logan plots using principal component analysis.

Authors:  Aniket Joshi; Jeffrey A Fessler; Robert A Koeppe
Journal:  J Cereb Blood Flow Metab       Date:  2007-12-05       Impact factor: 6.200

3.  Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes.

Authors:  M Pissarek; J Meyer-Kirchrath; T Hohlfeld; S Vollmar; A M Oros-Peusquens; U Flögel; C Jacoby; U Krügel; N Schramm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-07       Impact factor: 9.236

4.  Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.

Authors:  Tiina Saanijoki; Lauri Nummenmaa; Jetro J Tuulari; Lauri Tuominen; Eveliina Arponen; Kari K Kalliokoski; Jussi Hirvonen
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

5.  Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Authors:  Elise M Weerts; Gary S Wand; Hiroto Kuwabara; Cynthia A Munro; Robert F Dannals; John Hilton; J James Frost; Mary E McCaul
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

6.  Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.

Authors:  Lauri Tuominen; Lauri Nummenmaa; Liisa Keltikangas-Järvinen; Olli Raitakari; Jarmo Hietala
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

7.  Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.

Authors:  Michael G Feasel; Ariane Wohlfarth; John M Nilles; Shaokun Pang; Robert L Kristovich; Marilyn A Huestis
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

8.  Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.

Authors:  Riju Ray; Kosha Ruparel; Andrew Newberg; E Paul Wileyto; James W Loughead; Chaitanya Divgi; Julie A Blendy; Jean Logan; Jon-Kar Zubieta; Caryn Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

9.  Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.

Authors:  Tiina Saanijoki; Lauri Tuominen; Jetro J Tuulari; Lauri Nummenmaa; Eveliina Arponen; Kari Kalliokoski; Jussi Hirvonen
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

10.  Kinetic modelling of [11C]flumazenil using data-driven methods.

Authors:  Isabelle Miederer; Sibylle I Ziegler; Christoph Liedtke; Mary E Spilker; Matthias Miederer; Till Sprenger; Klaus J Wagner; Alexander Drzezga; Henning Boecker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.